display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - HR positive
la/mBC - HR positive - L2 - PIK3CA mutant
phosphoinositide 3-kinase (PI3K) inhibitor
buparlisib based treatment
buparlisib plus fulvestrant BELLE-2 ...

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons